People with HIV pioneers of injectable cabotegravir and rilpivirine long acting in Italy: who are they?
AIDS
; 38(3): 430-434, 2024 03 01.
Article
em En
| MEDLINE
| ID: mdl-38300162
ABSTRACT
Injectable cabotegravir and rilpivirine long-acting therapy is a revolutionary new antiretroviral treatment (ART) option for HIV infection in virologically suppressed adults on a stable ART. The aim of this study from SCOLTA multicenter observational prospective database is to describe the first people living with HIV (PWH) who started this regimen in Italy, assessing adherence to eligibility criteria, describing clinical-epidemiological characteristics compared to registration trials-population and describe early treatment-discontinuations.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Piridonas
/
Infecções por HIV
/
Dicetopiperazinas
/
Rilpivirina
Tipo de estudo:
Clinical_trials
Limite:
Adult
/
Humans
País/Região como assunto:
Europa
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article